KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Equity (2016 - 2025)

Historic Return on Equity for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to 0.14%.

  • Regeneron Pharmaceuticals' Return on Equity fell 100.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.15% for FY2025, which is 100.0% down from last year.
  • Per Regeneron Pharmaceuticals' latest filing, its Return on Equity stood at 0.14% for Q4 2025, which was down 100.0% from 0.15% recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Return on Equity ranged from a high of 0.46% in Q2 2021 and a low of 0.14% during Q4 2025
  • In the last 5 years, Regeneron Pharmaceuticals' Return on Equity had a median value of 0.17% in 2023 and averaged 0.24%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 1800bps in 2021, then crashed by -2500bps in 2022.
  • Over the past 5 years, Regeneron Pharmaceuticals' Return on Equity (Quarter) stood at 0.45% in 2021, then tumbled by -56bps to 0.2% in 2022, then decreased by -21bps to 0.16% in 2023, then fell by -3bps to 0.15% in 2024, then fell by -4bps to 0.14% in 2025.
  • Its Return on Equity was 0.14% in Q4 2025, compared to 0.15% in Q3 2025 and 0.15% in Q2 2025.